[1] JOHNSON DE,BURTNESS B,LEEMANS CR,et al.Head and neck squamous cell carcinoma[J].Nat Rev Dis Primers,2020,6(1):92.
[2] COHEN EEW,BELL RB,BIFULCO CB,et al.The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) [J].J Immunother Cancer,2019,7(1):184.
[3] ECHANIQUE KA,EVANS LK,HAN AY,et al.Cancer of the larynx and hypopharynx[J].Hematol Oncol Clin North Am,2021,35(5):933-947.
[4] COSTA SNL,FERNANDES FCGM,SOUZA DLB,et al.Incidence and mortality by larynx cancer in central and south America[J].Rev Gaucha Enferm,2021,42:e20190469.
[5] DENG Y,WANG M,ZHOU L,et al.Global burden of larynx cancer,1990-2017:estimates from the global burden of disease 2017 study[J].Aging (Albany NY),2020,12(3):2545-2583.
[6] LIU J,HUANG Y,LI T,et al.The role of the Golgi apparatus in disease (review) [J].Int J Mol Med,2021,47(4):38.
[7] LI H,ZHANG P,LUO J,et al.Chondroitin sulfate-linked prodrug nanoparticles target the golgi apparatus for cancer metastasis treatment[J].ACS Nano,2019,13(8):9386-9396.
[8] TAO Y,YANG Y,ZHOU R,et al.Golgi apparatus:an emerging platform for innate immunity[J].Trends Cell Biol,2020,30(6):467-477.
[9] ZHANG M,XU N,XU W,et al.Potential therapies and diagnosis based on golgi-targeted nano drug delivery systems[J].Pharmacol Res,2022,175:105861.
[10] GARCA-LEN FJ,GARCA-ESTEPA R,ROMERO-TABARES A,et al.Treatment of advanced laryngeal cancer and quality of life.Systematic review[J].Acta Otorrinolaringol Esp (Engl Ed),2017,68(4):212-219.
[11] LUJAN P,CAMPELO F.Should I stay or should I go? Golgi membrane spatial organization for protein sorting and retention[J].Arch Biochem Biophys,2021,707:108921.
[12] ZHANG X.Alterations of golgi structural proteins and glycosylation defects in cancer[J].Front Cell Dev Biol,2021,9:665289.
[13] MARTINS M,RAMOS CC,FREITAS D,et al.Glycosylation of cancer extracellular vesicles:capture strategies,functional roles and potential clinical applications[J].Cells,2021,10(1):109.
[14] JOHNSTON N,WELLS CW,SAMUELS TL,et al.Rationale for targeting pepsin in the treatment of reflux disease[J].Ann Otol Rhinol Laryngol,2010,119(8):547-558.
[15] 肖国岫,郑义彩,吴情,等.高尔基体整合膜蛋白4在人头颈癌中的表达及临床意义[J].现代口腔医学杂志,2020,34(05):277-280.
XIAO GX,ZHENG YC,WU Q,et al.Expression and clinical significance of golgi integral membrane protein 4 in head and neck cancer[J].Journal of Modern Stomatology,2020,34(05):277-280.
[16] LIN B,WANG S,YAO Y,et al.Comprehensive co-expression analysis reveals TMC8 as a prognostic immune-associated gene in head and neck squamous cancer[J].Oncol Lett,2021,22(1):498.
[17] YU Y,WANG Z,ZHENG Q,et al.GALNT2/14 overexpression correlate with prognosis and methylation:potential therapeutic targets for lung adenocarcinoma[J].Gene,2021,790:145689.
[18] 唐玉莲,陈启威,韦贵,等.PDGFA在鼻咽癌中的差异表达及其功能分析[J].右江民族医学院学报,2021,43(01):46-50.
TANG YL,CHEN QW,WEI G,et al.Differential expression and functional analysis of PDGFA in naspharyngeal carcinoma[J].Journal of Youjiang Medical University for Nationalities,2021,43(01):46-50.